Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF

Cited by (207)

Items 201–207 of 207

1. Targeting pulmonary fibrosis through Solanum xanthocarpum phytochemicals: A synergistic network pharmacology and docking investigation
   Megh Pravin Vithalkar, Bharath Harohalli Byregowda, B Krishnaprasad, Usha Y. Nayak, Fayaz SM, Sathyanarayana B, Yogendra Nayak · 2026 · Computers in Biology and Medicine
2. 4E-BP1 acts as a molecular rheostat balancing regenerative healing and fibrotic scarring
   Hanyu Dou, Jianzhou Li, Lin Lin, Mengyu Jin, Jingyuan Wang, Hequn Fu, Jiongming Lu, Qinyi Chen, 项蕾红, Juan Wang et al. · 2026 · Experimental & Molecular Medicine
3. Computational Investigation of Mangifera indica Seed Kernel Extract Against Radiation Induced Pulmonary Fibrosis: In vivo PDGF/PI3K-AKT/GSK3β Pathway
   Fatma A. Mokhtar, Nahla S. El‐Gazzar, Sebaey Mahgoub, Noha A. Fadel, Rania M. El‐Hazek, Walaa A. El‐Sabbagh · 2026 · Journal of Pharmaceutical Innovation
4. Fibronectin's tensional state as a mechanical signature of fibrotic extracellular matrix in idiopathic pulmonary fibrosis models
   Konstantin M. P. Wolf, Emmanouil Angelidakis, Daria Künzli, David Lauer, Matthias Brunner, Alessia Cambria, Divya Vats, Britta Maurer, Viola Vogel B, Mamta Chabria · 2026 · Matrix Biology Plus
5. BindingDB Entry 50018161: Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions.
   BindingDB · 2024 · UC San Diego
6. BindingDB Entry 50021579: Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways.
   BindingDB · 2025 · UC San Diego
7. BindingDB Entry 50007007: Discovery of 4-Methylquinazoline Based PI3K Inhibitors for the Potential Treatment of Idiopathic Pulmonary Fibrosis.
   BindingDB · 2021 · UC San Diego